List view / Grid view
Drug delivery refers to approaches for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect.
21 May 2015 | By Victoria White
Alnylam has filed a Clinical Trial Application to initiate a Phase 1/2 clinical trial with ALN-AAT for the treatment of alpha-1 liver disease...
19 May 2015 | By Victoria White
Dr Leenhouts is set to discuss the progress with Mucosis' intranasal respiratory syncytial virus (RSV) vaccine candidate, SynGEM, at MVADS 2015...
6 May 2015 | By Victoria White
Dicerna Pharmaceuticals has presented positive preclinical data on its proprietary DsiRNA-EX Conjugate-mediated delivery technology at TIDES 2015...
5 May 2015 | By Victoria White
The effectiveness of cancer vaccines could be dramatically boosted by first loading the cancer antigens into silicon microparticles...
27 April 2015 | By Victoria White
4DMT and Roche are to collaborate to discover and develop optimised next-generation AAV vectors for indications with high unmet medical need...
23 April 2015 | By Victoria White
Cytori Therapeutics presented data from two preclinical studies at ABA2015. The findings provide greater detail on Cytori's cell therapies...
30 March 2015 | By Victoria White
Around 6.5 million Europeans currently suffer from AMD. Nanoparticles could potentially be used as carriers for drug treatments instead of injections...
7 November 2014 | By CARLINA Technologies
CARLINA Technologies announces the signing of a collaborative agreement with GenBiotech for the development of a prolonged-release pharmaceutical form of a protein...
The recent developments in microfluidic technology have provided an effective microreactor platform for the production of a range of pharmaceutically related materials in both nano- and micro-scale. This can be attributed to the unique characteristics that microfluidic-based reactors offer in terms of controllability and uniformity of the material characteristics, compared…
Neutrons, electrically neutral particles found within the nucleus of the atom, are coming into their own in the exploration of new ways to get drugs to their targets. Neutron techniques are being used to investigate innovative new approaches to drug delivery that could increase the effectiveness of treatments, improve the…
Macrocyclic compounds (see Figure 1) have fascinated medicinal chemists for generations. The first ones which have been characterised are the naturally occurring cyclodextrins (CDs), cyclic oligomers of glucose, which can be obtained by bacterial synthesis from starch. Calixarenes (CXs) were among the first man-made macrocycles, followed by crown ethers (Pedersen,…
29 September 2014 | By SIGMOID PHARMA LIMITED
SIGMOID PHARMA LIMITED and Pendopharm have entered into agreements concerning a licence for exclusive rights to commercialise CyCol® in the Canadian market and an equity investment in SIGMOID...
5 August 2014 | By Roche
Roche announced that it has agreed to acquire Santaris Pharma, a privately held biopharmaceutical company based near Copenhagen, Denmark...
17 July 2014 | By Pfizer
Pfizer Inc. and InnoPharma, Inc. announced that they have entered into an agreement under which Pfizer will acquire InnoPharma...
